These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1686163)

  • 1. Design of a clinical trial to test a treatment of the underlying cause of emphysema.
    Anthonisen N; Connett J; Friedman B; Glass M; Kilday DP; Mingo TS; Rudolphus A; Williams GW
    Ann N Y Acad Sci; 1991 Dec; 624 Suppl():31-4. PubMed ID: 1686163
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials to treat the underlying cause of emphysema.
    Cohen AB
    Monaldi Arch Chest Dis; 1994 Apr; 49(2):95-7. PubMed ID: 8049708
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possibilities of the prevention and treatment of pulmonary emphysema in the light of the "proteolytic" theory of its pathogenesis].
    Nowak D
    Pneumonol Pol; 1985 Oct; 53(10):492-6. PubMed ID: 3912732
    [No Abstract]   [Full Text] [Related]  

  • 4. [New possibilities in the treatment of pulmonary emphysema based on the knowledge of the pathogenetic mechanisms of this disease].
    Krasucka-Kluźniak A
    Pneumonol Pol; 1983 Oct; 51(10):531-6. PubMed ID: 6361700
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cigarette smoking and the etiopathogenesis of pulmonary emphysema].
    Górecka D
    Pneumonol Pol; 1984 Jul; 52(7):353-7. PubMed ID: 6387638
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha-1-antitrypsin deficiency.
    Idell S; Cohen AB
    Clin Chest Med; 1983 Sep; 4(3):359-75. PubMed ID: 6357600
    [No Abstract]   [Full Text] [Related]  

  • 7. Opportunities for the development of specific therapeutic agents to treat emphysema.
    Cohen AB
    Am Rev Respir Dis; 1979 Oct; 120(4):723-7. PubMed ID: 389114
    [No Abstract]   [Full Text] [Related]  

  • 8. The potential role of elastase inhibitors in emphysema treatment.
    Eriksson S
    Eur Respir J; 1991 Oct; 4(9):1041-3. PubMed ID: 1684550
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy.
    Dirksen A; Dijkman JH; Madsen F; Stoel B; Hutchison DC; Ulrik CS; Skovgaard LT; Kok-Jensen A; Rudolphus A; Seersholm N; Vrooman HA; Reiber JH; Hansen NC; Heckscher T; Viskum K; Stolk J
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1468-72. PubMed ID: 10556107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The evolution of the replacement treatment of emphysema due to alpha 1-antitrypsin deficiency].
    Manresa F
    Arch Bronconeumol; 1995; 31(7):371-2. PubMed ID: 8777536
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
    Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The specific treatment of emphysema.
    Snider GL; Stone PJ; Lucey EC
    Eur Respir J Suppl; 1990 Mar; 9():23s-28s. PubMed ID: 2187448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Elastase, elastase inhibitors and chronic obstructive lung diseases].
    Kramps JA; Dijkman JH
    Ned Tijdschr Geneeskd; 1990 Jun; 134(23):1127-30. PubMed ID: 2192289
    [No Abstract]   [Full Text] [Related]  

  • 14. The fibrinogen cleavage product Aα-Val360, a specific marker of neutrophil elastase activity in vivo.
    Carter RI; Mumford RA; Treonze KM; Finke PE; Davies P; Si Q; Humes JL; Dirksen A; Piitulainen E; Ahmad A; Stockley RA
    Thorax; 2011 Aug; 66(8):686-91. PubMed ID: 21617168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease Modification in Emphysema Related to Alpha-1 Antitrypsin Deficiency.
    Chorostowska-Wynimko J
    COPD; 2016 Dec; 13(6):807-815. PubMed ID: 27172295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.
    Wewers MD; Casolaro MA; Sellers SE; Swayze SC; McPhaul KM; Wittes JT; Crystal RG
    N Engl J Med; 1987 Apr; 316(17):1055-62. PubMed ID: 3494198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency.
    Martorana PA; Brand T; Gardi C; van Even P; de Santi MM; Calzoni P; Marcolongo P; Lungarella G
    Lab Invest; 1993 Feb; 68(2):233-41. PubMed ID: 8441253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The elastase-antielastase hypothesis of the pathogenesis of emphysema.
    Stone PJ
    Clin Chest Med; 1983 Sep; 4(3):405-12. PubMed ID: 6196148
    [No Abstract]   [Full Text] [Related]  

  • 19. The feasibility of an outcome trial in the preventive therapy of emphysema.
    Glass M
    Ann N Y Acad Sci; 1991; 624():195-208. PubMed ID: 2064221
    [No Abstract]   [Full Text] [Related]  

  • 20. A matched-pair study of the leukocyte elastase-like activity in normal persons and in emphysematous patients with and without alpha 1-antitrypsin deficiency.
    Kramps JA; Bakker W; Dijkman JH
    Am Rev Respir Dis; 1980 Feb; 121(2):253-61. PubMed ID: 6965829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.